Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
16381-6 Androstenedione^5th specimen post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Androstenedione [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   16381-6         Observation       0 Androst sp5 p chal SerPl-mCnc       Y   After; CHEMISTRY.CHALLENGE TESTING; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR 2.34 1.0l               ng/dL       0
16382-4 Androstenedione^6th specimen post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Androstenedione [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   16382-4         Observation       0 Androst sp6 p chal SerPl-mCnc       Y   After; CHEMISTRY.CHALLENGE TESTING; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR 2.34 1.0l               ng/dL       0
16383-2 Androstenedione^7th specimen post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Androstenedione [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   16383-2         Observation       0 Androst sp7 p chal SerPl-mCnc       Y   ^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR 2.34 1.0l               ng/dL       0
16384-0 Androstenedione^8th specimen post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Androstenedione [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   16384-0         Observation       0 Androst sp8 p chal SerPl-mCnc       Y   After; CHEMISTRY.CHALLENGE TESTING; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR 2.34 1.0l               ng/dL       0
16385-7 Androstenedione^9th specimen post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Androstenedione [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   16385-7         Observation       0 Androst sp9 p chal SerPl-mCnc       Y   After; CHEMISTRY.CHALLENGE TESTING; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp9; sp9 p chal; Spec; SR 2.34 1.0l               ng/dL       0
16386-5 Rifabutin Susc Isolate Pt OrdQn MIC   DEPRECATED Deprecated Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)   DEL DefinitionDescription                   ABXBACT   16386-5   MIC     Observation       0 Deprecated Rifabutin Islt MIC           Ansamycin; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Mycobutin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.36 1.0l       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
16387-3 Rifabutin+Ethambutol Susc Isolate Pt OrdQn MIC   ACTIVE Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   16387-3   MIC     Observation       0 Rifabutin+Ethambutol Islt MIC           Ansamycin; ANTIBIOTIC SUSCEPTIBILITIES; AST; Etambol; Ethamb; ID; Inagen; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Myambutol; Mycobutin; Mycobutol; Olbutam; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1.0l                       0
16388-1 Anticonvulsants Prid Urine Pt Nom     ACTIVE Anticonvulsants [Identifier] in Urine   MIN DefinitionDescription                   DRUG/TOX   16388-1         Both       0 Anticonvulsants Ur           Anticonvuls; Anticonvulsant; Antiepileptic; Antiseizure; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn 2.73 1.0l                       0
16389-9 Antidepressants Prid Ser/Plas Pt Nom     ACTIVE Antidepressants [Identifier] in Serum or Plasma   MIN DefinitionDescription                   DRUG/TOX   16389-9         Both       0 Antidepressants SerPl           Addiction; Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Identity or presence; Illicit; Nominal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1.0l                       0
1639-4 Testosterone^pre 5000 U HCG IM MCnc Ser/Plas Pt Qn     ACTIVE Testosterone [Mass/volume] in Serum or Plasma --pre 5000 U HCG IM   MIN DefinitionDescription     ng/mL             CHAL   1639-4         Observation       0 Testost pre 5000 U CG IM SerPl-mCnc       Y   Before; CHEMISTRY.CHALLENGE TESTING; Chorionic gonadotropin stimulation test; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre 5000 U CG IM; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Testo; Testos; Testost 2.34 1               ng/mL       0
16390-7 Antidiuretics Prid Urine Pt Nom     ACTIVE Antidiuretics [Identifier] in Urine   MIN DefinitionDescription                   DRUG/TOX   16390-7         Both       0 Antidiuretics Ur           Antidiuretic; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn 2.19 1.0l                       0
16391-5 Antimony PrThr Urine Pt Ord     ACTIVE Antimony [Presence] in Urine   MIN DefinitionDescription                   DRUG/TOX   16391-5         Both       0 Antimony Ur Ql           DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; SB; Screen; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16392-3 Nuclear Ab PrThr Ser Pt Ord Rodent substrate   ACTIVE Nuclear Ab [Presence] in Serum by Rodent substrate   MIN DefinitionDescription                   SERO   16392-3   Rodent substrate     Both       0 ANA Ser Ql Rodent subst           ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR 2.73 1.0l                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16393-1 Nuclear Ab ACnc Ser Pt Qn Rodent substrate   ACTIVE Nuclear Ab [Units/volume] in Serum by Rodent substrate   MIN DefinitionDescription                   SERO   16393-1   Rodent substrate     Both       0 ANA Ser Rodent subst-aCnc       Y   ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR 2.69 1.0l               [arb'U]/mL       0
16394-9 Nuclear Ab PrThr Body fld Pt Ord IF   ACTIVE Nuclear Ab [Presence] in Body fluid by Immunofluorescence   MIN DefinitionDescription                   SERO   16394-9   IF     Both       0 ANA Fld Ql IF           ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; FA; FANA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Time Resolved Fluorescence; TRF 2.56 1.0l                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16395-6 Antipsychotics Prid Urine Pt Nom     ACTIVE Antipsychotics [Identifier] in Urine   MIN DefinitionDescription                   DRUG/TOX   16395-6         Both       0 Antipsychotics Ur           Antipsychotic; DRUG/TOXICOLOGY; Drugs; Identity or presence; neuroleptics; Nominal; Point in time; Random; UA; UR; Urn 2.73 1.0l                       0
164-4 Cephapirin Susc Isolate Pt Qn MLC   ACTIVE Cephapirin [Susceptibility] by Minimum lethal concentration (MLC)   MIN DefinitionDescription                   ABXBACT   164-4   MLC     Observation       0 Cephapirin Islt MLC       Y   ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefadyl; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1                       0
1640-2 Thyrotropin^30M post dose TRH IV MCnc Ser/Plas Pt Qn     DISCOURAGED Thyrotropin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV   MIN DefinitionDescription     ng/mL             CHAL   1640-2         Observation       0 TSH 30M p TRH IV SerPl-mCnc       Y   30M p TRH; 30M p TRH IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH 2.73 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
16400-4 Observation Aper Semin plas Pt Nom     ACTIVE Appearance of Seminal plasma   NAM DefinitionDescription                   SPEC   16400-4         Observation       0 Appearance Semin plas           Appearance; Nominal; Pl; Plasma; Plsm; Point in time; Random; Seminal plasma; SPEC 2.79 1.0l                     Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forthââ?¬Â¦; 0
16401-2 Arginine PrThr Urine Pt Ord     ACTIVE Arginine [Presence] in Urine   MIN DefinitionDescription                   CHEM   16401-2         Observation       0 Arginine Ur Ql           Arg; Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.56 1.0l                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16402-0 Aromatic solvents Prid Bld Pt Nom     ACTIVE Aromatic solvents [Identifier] in Blood   MIN DefinitionDescription                   DRUG/TOX   16402-0         Both       0 Arom Solvents Bld           Arom Solvents; Blood; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; WB; Whole blood 2.07 1.0l                       0
16403-8 Arsenic PrThr Ser/Plas Pt Ord     ACTIVE Arsenic [Presence] in Serum or Plasma   MIN DefinitionDescription                   DRUG/TOX   16403-8         Both       0 Arsenic SerPl Ql           AS; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.56 1.0l                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16404-6 Arsenic PrThr Urine Pt Ord     ACTIVE Arsenic [Presence] in Urine   MIN DefinitionDescription                   DRUG/TOX   16404-6         Both       0 Arsenic Ur Ql           AS; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16405-3 Arylamidase PrThr Urine Pt Ord     ACTIVE Arylamidase [Presence] in Urine   MIN DefinitionDescription                   CHEM   16405-3         Both       0 Arylamidase Ur Ql           Chemistry; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.56 1.0l                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
16406-1 Arylamidase CCnc Urine Pt Qn     ACTIVE Arylamidase [Enzymatic activity/volume] in Urine   MIN DefinitionDescription     arb U/L             CHEM   16406-1         Both       0 Arylamidase Ur-cCnc       Y   Catalytic Concentration; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.68 1.0l               U/L       0
104,672 results found